Metal-Based Nanoparticles for Pharmaceutical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (15 September 2024) | Viewed by 11854
Special Issue Editors
Interests: extracellular vesicles; differentiation; neuroinflammation; apoptosis; autophagy; nanotoxicology; drug delivery; cancer therapy; neurodegenerative diseases; nanoparticles
Special Issues, Collections and Topics in MDPI journals
Interests: nanotoxicology; nanoplastics; microplastics; nanomaterials; nano-biointeraction; drug delivery; nanosafety; ecotoxicology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metal-based nanoparticles (MNPs) stand out as nanotechnological solutions for a wide range of open biological and medical physio/pathological questions in biomedicine.
Their optical, magnetic, and electrical activities make them very important as nanoparticle-based image tools to be used in early diagnoses; furthermore, their capability to generate reactive oxygen species (ROS), possessing multiple biological functions in health and disease, suggests their potential exploitation for the development of new therapies. Finally, their potential use as theranostic agents could result in great and exciting progressions for personalized medicine.
This Special Issue aims to collect manuscripts from all scientists producing and/or applying metal nanoparticles in a diagnostic, therapeutic, or theranostics context, providing an insight into the latest advances in the field of nanomedicine with emphasis on the benefits, limitations, and future directions of utilizing metal nanoparticles in pharmaceutical applications. Original research papers and review articles are warmly welcomed.
Dr. Elisa Panzarini
Dr. Stefania Mariano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metal-based nanoparticles
- theranostics
- bioimaging
- cancer therapy
- drug delivery systems
- nanomedicine
- cell death
- nanotoxicology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.